Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Regenerative Biomaterials is Scopus-indexed (Q1, CiteScore 11.8), WoS SCIE, DOAJ. Published by Oxford University Press.
Checked against the index lists dated .
ISSN 2056-3418Verify ISSN ↗2056-3426Verify ISSN ↗
Publisher: Oxford University Press
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biomedical Engineering | 46 / 342 | 86th | Q1 |
| Biomaterials | 27 / 146 | 81st | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q1, CiteScore 11.8.
Regenerative Biomaterials is Q1 in Biomedical Engineering (rank 46 of 342) and Q1 in Biomaterials (rank 27 of 146), by CiteScore 2025.
Regenerative Biomaterials is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 11.8, which places it in quartile Q1 at the 86th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.387, quartile Q1, with an H-index of 56.
The publisher lists an article processing charge of about US$1,820 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Regenerative Biomaterials is published by Oxford University Press. Its print ISSN is 2056-3418 and its online ISSN is 2056-3426.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Regenerative Biomaterials has an h-index of 67 and a 2-year mean of 7.57 citations per paper (OpenAlex). Its Scopus CiteScore is 11.8, quartile Q1. On 2-year citations it ranks #34 of 322 Scopus journals in Biomedical Engineering.
Regenerative Biomaterials published 138 papers in 2025; its busiest recent year was 2024 with 150. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (84%), United States (3%) and Germany (2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.